Dare Bioscience, Inc. Research and Development Expense
Dare Bioscience, Inc. (DARE) reported Research and Development Expense of $241.97 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- Dare Bioscience, Inc. research and development expense for the quarter ending 2026-06-30 was $241.97K, a 83.06% decline year-over-year.
- Dare Bioscience, Inc. research and development expense for the quarter ending 2026-03-31 was $660.46K, a 71.25% decline year-over-year.
- Dare Bioscience, Inc. research and development expense for the quarter ending 2025-12-31 was $622.04K, a 81.35% decline year-over-year.
- Dare Bioscience, Inc. research and development expense for the quarter ending 2025-09-30 was $1.18M, a 56.18% decline year-over-year.
- Dare Bioscience, Inc. research and development expense for fiscal 2025 was $5.52M, a 61.39% decline from fiscal 2024.
- Dare Bioscience, Inc. research and development expense for fiscal 2024 was $14.31M, a 33.58% decline from fiscal 2023.
- Dare Bioscience, Inc. research and development expense for fiscal 2023 was $21.54M, a 28.31% decline from fiscal 2022.
- Dare Bioscience, Inc. research and development expense for fiscal 2022 was $30.04M, a 1.88% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 100 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $241.97K 10-Q · filed 2026-08-13 | $902.43K 10-Q · filed 2026-08-13 | $1.52M derived: sum of 3 quarters · filed 2026-08-13 | $2.70M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $660.46K 10-Q · filed 2026-05-14 | $1.28M derived: sum of 2 quarters · filed 2026-05-14 | $2.46M derived: sum of 3 quarters · filed 2026-05-14 | $3.89M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | $622.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.80M derived: sum of 2 quarters · filed 2026-03-26 | $3.23M derived: sum of 3 quarters · filed 2026-08-13 | $5.52M 10-K · filed 2026-03-26 | |||||
| 2025-09-30 | $1.18M 10-Q · filed 2025-11-13 | $2.60M derived: sum of 2 quarters · filed 2026-08-13 | $4.90M 10-Q · filed 2025-11-13 | $8.24M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $1.43M 10-Q · filed 2026-08-13 | $3.73M 10-Q · filed 2026-08-13 | $7.06M derived: sum of 3 quarters · filed 2026-08-13 | $9.74M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $2.30M 10-Q · filed 2026-05-14 | $5.63M derived: sum of 2 quarters · filed 2026-05-14 | $8.32M derived: sum of 3 quarters · filed 2026-05-14 | $13.25M derived: sum of 4 quarters · filed 2026-05-14 | |||||
| 2024-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $6.02M derived: sum of 2 quarters · filed 2026-03-26 | $10.95M derived: sum of 3 quarters · filed 2026-03-26 | $14.31M 10-K · filed 2026-03-26 | $14.21M 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $2.68M 10-Q · filed 2025-11-13 | $2.66M 10-Q · filed 2024-11-14 | $7.62M derived: sum of 2 quarters · filed 2025-11-13 | $10.97M 10-Q · filed 2025-11-13 | $10.89M 10-Q · filed 2024-11-14 | $14.77M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $4.93M 10-Q · filed 2025-08-14 | $4.91M 10-Q · filed 2024-08-12 | $8.29M 10-Q · filed 2025-08-14 | $8.24M 10-Q · filed 2024-08-12 | $12.09M derived: sum of 3 quarters · filed 2025-08-14 | $18.76M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $3.35M 10-Q · filed 2025-05-13 | $3.33M 10-Q · filed 2024-05-14 | $7.15M derived: sum of 2 quarters · filed 2025-05-13 | $13.83M derived: sum of 3 quarters · filed 2025-05-13 | $19.87M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $10.47M derived: sum of 2 quarters · filed 2025-03-31 | $16.52M derived: sum of 3 quarters · filed 2025-03-31 | $21.54M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $6.67M 10-Q · filed 2024-11-14 | $12.72M derived: sum of 2 quarters · filed 2024-11-14 | $17.74M 10-Q · filed 2024-11-14 | $30.72M derived: sum of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | $6.04M 10-Q · filed 2024-08-12 | $11.06M 10-Q · filed 2024-08-12 | $24.04M derived: sum of 3 quarters · filed 2024-08-12 | $28.50M derived: sum of 4 quarters · filed 2024-08-12 | |||||
| 2023-03-31 | $5.02M 10-Q · filed 2024-05-14 | $18.00M derived: sum of 2 quarters · filed 2024-05-14 | $22.46M derived: sum of 3 quarters · filed 2024-05-14 | $29.26M derived: sum of 4 quarters · filed 2024-05-14 | |||||
| 2022-12-31 | $12.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $17.44M derived: sum of 2 quarters · filed 2024-03-28 | $24.24M derived: sum of 3 quarters · filed 2024-03-28 | $30.04M 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | $4.46M 10-Q · filed 2023-11-09 | $11.26M derived: sum of 2 quarters · filed 2023-11-09 | $17.07M 10-Q · filed 2023-11-09 | $24.18M derived: sum of 4 quarters · filed 2023-11-09 | |||||
| 2022-06-30 | $6.80M 10-Q · filed 2023-08-10 | $12.60M 10-Q · filed 2023-08-10 | $19.72M derived: sum of 3 quarters · filed 2023-08-10 | $30.15M derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | $5.81M 10-Q · filed 2023-05-11 | $12.92M derived: sum of 2 quarters · filed 2023-05-11 | $23.35M derived: sum of 3 quarters · filed 2023-05-11 | $30.69M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $7.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $17.55M derived: sum of 2 quarters · filed 2023-03-30 | $24.89M derived: sum of 3 quarters · filed 2023-03-30 | $30.62M 10-K · filed 2023-03-30 | |||||
| 2021-09-30 | $10.43M 10-Q · filed 2022-11-10 | $17.77M derived: sum of 2 quarters · filed 2022-11-10 | $23.50M 10-Q · filed 2022-11-10 | $30.14M derived: sum of 4 quarters · filed 2022-11-10 | |||||
| 2021-06-30 | $7.34M 10-Q · filed 2022-08-09 | $13.07M 10-Q · filed 2022-08-09 | $19.71M derived: sum of 3 quarters · filed 2022-08-09 | $25.91M derived: sum of 4 quarters · filed 2022-08-09 | |||||
| 2021-03-31 | $5.73M 10-Q · filed 2022-05-12 | $12.37M derived: sum of 2 quarters · filed 2022-05-12 | $18.57M derived: sum of 3 quarters · filed 2022-05-12 | $24.12M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $6.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $12.84M derived: sum of 2 quarters · filed 2022-03-31 | $18.39M derived: sum of 3 quarters · filed 2022-03-31 | $20.77M 10-K · filed 2022-03-31 | |||||
| 2020-09-30 | $6.20M 10-Q · filed 2021-11-10 | $11.75M derived: sum of 2 quarters · filed 2021-11-10 | $14.13M 10-Q · filed 2021-11-10 | $16.50M derived: sum of 4 quarters · filed 2021-11-10 | |||||
| 2020-06-30 | $5.55M 10-Q · filed 2021-08-12 | $7.93M 10-Q · filed 2021-08-12 | $10.30M derived: sum of 3 quarters · filed 2021-08-12 | $12.27M derived: sum of 4 quarters · filed 2021-08-12 | |||||
| 2020-03-31 | $2.38M 10-Q · filed 2021-05-13 | $4.75M derived: sum of 2 quarters · filed 2021-05-13 | $6.72M derived: sum of 3 quarters · filed 2021-05-13 | $9.23M derived: sum of 4 quarters · filed 2021-05-13 | |||||
| 2019-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $4.34M derived: sum of 2 quarters · filed 2021-03-30 | $6.85M derived: sum of 3 quarters · filed 2021-03-30 | $8.55M 10-K · filed 2021-03-30 | |||||
| 2019-09-30 | $1.97M 10-Q · filed 2020-11-12 | $4.48M derived: sum of 2 quarters · filed 2020-11-12 | $6.17M 10-Q · filed 2020-11-12 | $7.84M derived: sum of 4 quarters · filed 2020-11-12 | |||||
| 2019-06-30 | $2.51M 10-Q · filed 2020-08-12 | $4.21M 10-Q · filed 2020-08-12 | $5.87M derived: sum of 3 quarters · filed 2020-08-12 | $7.32M derived: sum of 4 quarters · filed 2020-08-12 | |||||
| 2019-03-31 | $1.69M 10-Q · filed 2020-05-14 | $3.36M derived: sum of 2 quarters · filed 2020-05-14 | $4.80M derived: sum of 3 quarters · filed 2020-05-14 | $7.02M derived: sum of 4 quarters · filed 2020-05-14 | |||||
| 2018-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $3.11M derived: sum of 2 quarters · filed 2020-03-27 | $5.33M derived: sum of 3 quarters · filed 2020-03-27 | $6.41M 10-K · filed 2020-03-27 | |||||
| 2018-09-30 | $1.45M 10-Q · filed 2019-11-12 | $3.66M derived: sum of 2 quarters · filed 2019-11-12 | $4.75M 10-Q · filed 2019-11-12 | $5.42M derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2018-06-30 | $2.22M 10-Q · filed 2019-08-14 | $3.30M 10-Q · filed 2019-08-14 | $3.98M derived: sum of 3 quarters · filed 2019-08-14 | $4.26M derived: sum of 4 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | $1.09M 10-Q · filed 2019-05-14 | $1.76M derived: sum of 2 quarters · filed 2019-05-14 | $2.04M derived: sum of 3 quarters · filed 2019-05-14 | $2.04M derived: sum of 4 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $672.58K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $953.37K derived: sum of 2 quarters · filed 2019-04-01 | $956.95K derived: sum of 3 quarters · filed 2019-04-01 | $984.75K 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | $280.79K 10-Q · filed 2018-11-13 | $284.37K derived: sum of 2 quarters · filed 2018-11-13 | $312.17K 10-Q · filed 2018-11-13 | $3.50M derived: sum of 4 quarters · filed 2018-11-13 | |||||
| 2017-06-30 | $3.58K 10-Q · filed 2018-08-13 | $1.29M 10-Q · filed 2017-08-14 | $31.38K 10-Q · filed 2018-08-13 | $5.94M 10-Q · filed 2017-08-14 | $3.22M derived: sum of 3 quarters · filed 2018-08-13 | $10.30M derived: sum of 4 quarters · filed 2018-08-13 | |||
| 2017-03-31 | $27.80K 10-Q · filed 2018-05-14 | $4.65M 10-Q · filed 2017-05-12 | $3.21M derived: sum of 2 quarters · filed 2018-05-14 | $10.30M derived: sum of 3 quarters · filed 2018-05-14 | $17.82M derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $3.18M 10-K/A · filed 2017-06-13 | $10.27M derived: sum of 2 quarters · filed 2017-06-13 | $17.80M derived: sum of 3 quarters · filed 2017-08-14 | $72.67K 10-K · filed 2018-03-28 | $27.57M 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | $7.09M 10-K/A · filed 2017-06-13 | $14.61M derived: sum of 2 quarters · filed 2017-08-14 | $72.67K 10-Q · filed 2017-11-13 | $24.38M 10-Q · filed 2016-11-03 | $31.54M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-06-30 | $7.52M 10-Q · filed 2017-08-14 | $17.29M 10-Q · filed 2017-08-14 | $24.45M derived: sum of 3 quarters · filed 2017-08-14 | $31.54M derived: sum of 4 quarters · filed 2017-08-14 | |||||
| 2016-03-31 | $9.77M 10-K/A · filed 2017-06-13 | $16.93M derived: sum of 2 quarters · filed 2017-06-13 | $24.02M derived: sum of 3 quarters · filed 2017-06-13 | $30.70M derived: sum of 4 quarters · filed 2017-06-13 | |||||
| 2015-12-31 | $7.16M 10-K/A · filed 2017-06-13 | $14.25M derived: sum of 2 quarters · filed 2017-06-13 | $20.93M derived: sum of 3 quarters · filed 2017-06-13 | $25.95M 10-K/A · filed 2017-06-13 | |||||
| 2015-09-30 | $7.09M 10-K/A · filed 2017-06-13 | $13.77M derived: sum of 2 quarters · filed 2017-06-13 | $18.79M 10-Q · filed 2016-11-03 | $23.49M derived: sum of 4 quarters · filed 2017-06-13 | |||||
| 2015-06-30 | $6.68M 10-K/A · filed 2017-06-13 | $11.70M 10-Q · filed 2016-08-04 | $16.40M derived: sum of 3 quarters · filed 2017-06-13 | $19.33M derived: sum of 4 quarters · filed 2017-06-13 | |||||
| 2015-03-31 | $5.02M 10-K/A · filed 2017-06-13 | $9.72M derived: sum of 2 quarters · filed 2017-06-13 | $12.65M derived: sum of 3 quarters · filed 2017-06-13 | $15.30M derived: sum of 4 quarters · filed 2017-06-13 | |||||
| 2014-12-31 | $4.70M 10-K · filed 2016-03-10 | $7.63M derived: sum of 2 quarters · filed 2016-03-10 | $10.28M derived: sum of 3 quarters · filed 2016-03-10 | $11.77M 10-K/A · filed 2017-06-13 | |||||
| 2014-09-30 | $2.93M 10-K · filed 2016-03-10 | $5.58M derived: sum of 2 quarters · filed 2016-03-10 | $7.07M 10-Q · filed 2015-11-16 | $8.51M derived: sum of 4 quarters · filed 2016-03-10 | |||||
| 2014-06-30 | $2.65M 10-K · filed 2016-03-10 | $4.14M 10-Q · filed 2015-08-06 | $5.58M derived: sum of 3 quarters · filed 2016-03-10 | $7.17M derived: sum of 4 quarters · filed 2016-03-10 | |||||
| 2014-03-31 | $1.50M 10-K · filed 2016-03-10 | $2.94M derived: sum of 2 quarters · filed 2016-03-10 | $4.52M derived: sum of 3 quarters · filed 2016-03-10 | $7.72M derived: sum of 4 quarters · filed 2016-03-10 | $68.54M 10-Q · filed 2014-05-27 | ||||
| 2013-12-31 | $1.44M 10-K · filed 2015-03-19 | $3.03M derived: sum of 2 quarters · filed 2015-03-19 | $6.22M derived: sum of 3 quarters · filed 2015-03-19 | $9.70M 10-K · filed 2016-03-10 | |||||
| 2013-09-30 | $1.59M 10-K · filed 2015-03-19 | $4.78M derived: sum of 2 quarters · filed 2015-03-19 | $8.26M 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | $3.19M 10-K · filed 2015-03-19 | $6.67M 10-Q · filed 2014-08-12 | |||||||
| 2013-03-31 | $3.48M 10-K · filed 2015-03-19 | ||||||||
| 2012-12-31 | $15.81M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |